Work

Advances in Small Molecule Inhibitors for Cancer Inflammation and Autoimmune Diseases

Year: 2025

Type: article

Abstract: Small molecule inhibitors have emerged as pivotal therapeutic agents in targeting cancer, inflammation, and autoimmune diseases. These compounds are designed to interfere with specific molecular pathways, offering improved efficacy and reduced side effects. This review explores the latest advances in small molecule inhibitors, highlighting key mechanisms, recent clinical developments, and future directions in their application for disease treatment.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.15147734

Author: Aditi Jyotishi*1, Roshani Bhavsar2, Chetan Kedari3, Ashvini Patmase4, Shubham Ahir5, Kamran Ahmad Shaikh Zaheer Ahmed5

Language: English

Topic: Synthesis and biological activity

Subfield: Organic Chemistry

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6949520227

FWCI:

Cites:

Cited by:

Related to: